BioNTech SE (BNTX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 21.34B |
| Enterprise value | 3.94B |
| Trailing P/E | 21.70 |
| Forward P/E | 7.04 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 5.28 |
| Price/book (mrq) | 0.99 |
| Enterprise value/revenue | 1.03 |
| Enterprise value/EBITDA | 3.62 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.23 |
| 52-week change 3 | -19.99% |
| S&P500 52-week change 3 | 25.01% |
| 52-week high 3 | 125.83 |
| 52-week low 3 | 85.21 |
| 50-day moving average 3 | 91.06 |
| 200-day moving average 3 | 101.22 |
Share statistics
| Avg vol (3-month) 3 | 634.15k |
| Avg vol (10-day) 3 | 757.69k |
| Shares outstanding 5 | 240.99M |
| Implied shares outstanding 6 | 240.99M |
| Float 8 | 88.96M |
| % held by insiders 1 | 62.84% |
| % held by institutions 1 | 18.34% |
| Shares short (28 Mar 2024) 4 | 3.08M |
| Short ratio (28 Mar 2024) 4 | 4.33 |
| Short % of float (28 Mar 2024) 4 | 6.42% |
| Short % of shares outstanding (28 Mar 2024) 4 | 1.29% |
| Shares short (prior month 29 Feb 2024) 4 | 2.92M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 17 June 2022 |
| Ex-dividend date 4 | 02 June 2022 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in EUR.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 24.36% |
| Operating margin (ttm) | 40.00% |
Management effectiveness
| Return on assets (ttm) | 2.62% |
| Return on equity (ttm) | 4.62% |
Income statement
| Revenue (ttm) | 3.82B |
| Revenue per share (ttm) | 15.87 |
| Quarterly revenue growth (yoy) | -65.40% |
| Gross profit (ttm) | N/A |
| EBITDA | 1.11B |
| Net income avi to common (ttm) | 930.3M |
| Diluted EPS (ttm) | 4.08 |
| Quarterly earnings growth (yoy) | -79.90% |
Balance sheet
| Total cash (mrq) | 16.55B |
| Total cash per share (mrq) | 69.61 |
| Total debt (mrq) | 219.1M |
| Total debt/equity (mrq) | 1.08% |
| Current ratio (mrq) | 9.43 |
| Book value per share (mrq) | 85.17 |
Cash flow statement
| Operating cash flow (ttm) | 5.37B |
| Levered free cash flow (ttm) | 4.14B |
© 2024 Yahoo. All rights reserved.